SCTX Scribe Therapeutics Inc.
$29.74▲ +0.92%
Healthcare
Other
After hours
$29.50▼ -0.80%
Sep 11, 7:30 PM ET
Volume 141.2K
Avg Volume (10D) 184.8K
Key Metrics & Fundamentals
Market Cap
$563.03M
P/E Ratio
–
Div Yield
–%
52W Range
17.31 - 39.60
% vs 50 MA
–%
% vs 200 MA
–%
RSI-14
53.4
MACD Histogram
-0.7800
Beta (1Y vs SPY)
-0.37
Free Cash Flow
-$5.35M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
-$6.48M
Price & Volume History
Loading chart…
Recent News

Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · Sep 2, 2026 8:05 PM

Scribe Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 12:00 PM

Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
The Fly · Aug 31, 2026 1:45 PM
Top Premarket Gainers
MT Newswires · Aug 24, 2026 11:13 AM

Norwegian Cruise downgrade, Duolingo upgraded: Wall Street's top analyst calls
The Fly · Aug 18, 2026 1:37 PM
Scribe’s Genetic Editing Aims to Prevent Heart Attacks
Barrons.com · Jul 30, 2026 2:26 PM
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
GlobeNewswire · Jul 27, 2026 8:05 PM
Scribe Therapeutics Soars 67% After $128.7 Million Upsized IPO
GuruFocus.com · Jul 24, 2026 6:45 PM
Top Midday Gainers
MT Newswires · Jul 24, 2026 5:38 PM
Sector Update: Healthcare Stocks Rise in Afternoon Trading
MT Newswires · Jul 24, 2026 5:26 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See SCTX's money flow as a full page
Social Sentiment
No Reddit posts found for SCTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.